Adaptive Biotechnologies’ Split Isn’t a Retreat — It’s a Confession That One Company Can’t Serve Two Masters
Adaptive Biotechnologies separates its profitable $145M MRD diagnostics unit from its AI-driven TCR platform, betting two focused stories beat...